John Anthony Chanasue, MD in Alton, IL - Dermatology

John Anthony Chanasue, MD is a Dermatology physician based in Alton, Illinois. John Anthony Chanasue is licensed to practice in Illinois (license number ) and his current practice location is 307 Henry St, Ste 200, Alton, Illinois. He can be reached at his office (for appointments etc.) via phone at (618) 463-9623.

NPI number for John Anthony Chanasue is 1972618387 and his current mailing address is 307 Henry St, Ste 200, Alton, Illinois. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1972618387.

Contact Information

	John Anthony Chanasue, MD
	307 Henry St, Ste 200, Alton, IL 62002-6326
	(618) 463-9623
	(618) 462-8591

Physician's Profile

Full Name	John Anthony Chanasue
Gender	Male
Speciality	Dermatology
Location	307 Henry St, Alton, Illinois
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1972618387
Provider Enumeration Date: 08/19/2006
Last Update Date: 07/08/2007

Medical Identifiers

Medical identifiers for John Anthony Chanasue such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1972618387	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207N00000X	Dermatology	(Illinois)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. John Anthony Chanasue is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
John Anthony Chanasue, MD 307 Henry St, Ste 200, Alton, IL 62002-6326 Ph: (618) 463-9623	John Anthony Chanasue, MD 307 Henry St, Ste 200, Alton, IL 62002-6326 Ph: (618) 463-9623

News Archive

Scientists unravel first step in translating genetic information in order to build a protein

Timing is everything, it seems, even in science. A team led by Johns Hopkins scientists has unraveled the first step in translating genetic information in order to build a protein, only to find that it's not one step but two.

New view of photosynthesis

During the remarkable cascade of events of photosynthesis, plants approach the pinnacle of stinginess by scavenging nearly every photon of available light energy to produce food.

New article explores ethical issues and global health impact of counterterrorism

The surge in murders of polio vaccination workers in Pakistan has made headlines this year, but little attention has been devoted to the ethical issues surrounding the global health impact of current counterterrorism policy and practice. An essay in the Hastings Center Report reviews the range of harms to population health traceable to counterterrorism operations.

Scientists claim signs of lasting SARS-CoV-2 immunity

Questions have been raised by many health experts on whether being infected with SARS-CoV-2 brings lasting immunity. Now, scientists have uncovered signs of strong and lasting immunity in people who even had a mild illness of COVID-19.

Labopharm commences regulatory approval process in Europe for its twice-daily tramadol-acetaminophen

Labopharm Inc. today announced it has initiated the regulatory approval process for its twice-daily tramadol-acetaminophen formulation in Europe under the Decentralized Procedure (DCP). The DCP provides an efficient mechanism that allows a company to simultaneously pursue regulatory approval for a medicinal product in multiple jurisdictions in Europe.

John Anthony Chanasue, MD - Dermatology in Alton, IL